Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress
暂无分享,去创建一个
[1] E. Bruckert,et al. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. , 1998, European heart journal.
[2] G. Francis,et al. High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences. , 2000, Biochimica et biophysica acta.
[3] J. Gamble,et al. Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[4] G. Assmann,et al. Physiological role and clinical relevance of high‐density lipoprotein subclasses , 1994, Current opinion in lipidology.
[5] R. Stocker,et al. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[6] A. Tselepis,et al. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. , 2002, Atherosclerosis. Supplements.
[7] Jonathan D. Smith,et al. Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.
[8] P. Durrington,et al. Paraoxonase and Atherosclerosis , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[9] D. Shih,et al. The role of high-density lipoproteins in oxidation and inflammation. , 2001, Trends in cardiovascular medicine.
[10] A. Nègre-Salvayre,et al. Mildly oxidized LDL particle subspecies are distinct in their capacity to induce apoptosis in endothelial cells: role of lipid hydroperoxides , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] J P Kane,et al. Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Stengel,et al. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[13] S. Reddy,et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. , 2000, Journal of lipid research.
[14] J. Heinecke,et al. Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis. , 2001, Trends in cardiovascular medicine.
[15] R. Krauss,et al. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility. , 1999, Biochimica et biophysica acta.
[16] Z. Huang,et al. Mechanism of high-density lipoprotein subfractions inhibiting copper-catalyzed oxidation of low-density lipoprotein. , 1998, Clinical biochemistry.
[17] D. Steinberg,et al. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? , 2001, Trends in cardiovascular medicine.
[18] G. Fonarow,et al. formation of , 2022 .
[19] C. Furlong,et al. Apolipoprotein J is associated with paraoxonase in human plasma. , 1994, Biochemistry.
[20] S. Biasioli,et al. HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[21] James W. Anderson,et al. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[22] G. Getz,et al. Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. , 2003, Journal of lipid research.
[23] J. S. Owen,et al. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein. , 1997, Atherosclerosis.
[24] J. Dallongeville,et al. Apolipoprotein A-I-containing lipoproteins and atherosclerosis , 1995, Current opinion in lipidology.
[25] P. Lesnik,et al. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[26] J. Wittes,et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. , 2001, JAMA.
[27] B. Engelmann,et al. Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and alpha-tocopherol. , 1999, Free radical biology & medicine.
[28] A. Scanu,et al. In vitro mass: activity distribution of lecithin--cholesterol acyltransferase among human plasma lipoproteins. , 1982, Atherosclerosis.
[29] D. Stengel,et al. Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II. , 2002, Journal of lipid research.
[30] J. Ribalta,et al. Antioxidative and Antiatherosclerotic Effects of Human Apolipoprotein A-IV in Apolipoprotein E-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[31] E. Schnitzer,et al. The effect of albumin on copper-induced LDL oxidation. , 1997, Biochimica et biophysica acta.
[32] J. Holtzman,et al. Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides. , 2000, The Journal of laboratory and clinical medicine.
[33] M. Chapman,et al. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[34] W. J. Johnson,et al. Effects of Acceptor Particle Size on the Efflux of Cellular Free Cholesterol (*) , 1995, The Journal of Biological Chemistry.
[35] T. Fujinami,et al. HDL3 exerts more powerful anti-oxidative, protective effects against copper-catalyzed LDL oxidation than HDL2. , 1997, Clinical biochemistry.
[36] J. Goudevenos,et al. Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia. , 2002, Journal of lipid research.
[37] G. Lewis,et al. HDL metabolism in hypertriglyceridemic states: an overview. , 1999, Clinica chimica acta; international journal of clinical chemistry.
[38] D. Lichtenberg,et al. Kinetics of lipid peroxidation in mixtures of HDL and LDL, mutual effects. , 2001, Free radical biology & medicine.
[39] M. Couturier,et al. Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[40] S. Dhanjil,et al. High-density lipoprotein composition and paraoxonase activity in Type I diabetes. , 2001, Clinical science.
[41] B. La Du,et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. , 1999, Free radical biology & medicine.
[42] Ming Liu,et al. Novel Function of Lecithin-Cholesterol Acyltransferase , 1997, The Journal of Biological Chemistry.
[43] S. Goldstein,et al. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. , 1981, Journal of lipid research.